Vinpocetine

Vinpocetine
Clinical data
Trade namesCavinton, others
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • Not recommended
Routes of
administration
Oral, intravenous
ATC code
Legal status
Legal status
  • US: Unapproved "New Drug" (as defined by 21 U.S. Code § 321(p)(1)). Use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled.
  • EU: Rx-only
Pharmacokinetic data
Bioavailability56.6 ± 8.9%
Metabolismhepatic
Elimination half-life2.54 ± 0.48 hours
Excretionrenal
Identifiers
  • (3α,16α)-Eburnamenine-14-carboxylic acid ethyl ester
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.050.917
Chemical and physical data
FormulaC22H26N2O2
Molar mass350.462 g·mol−1
3D model (JSmol)
  • O=C(OCC)C=4n1c3c(c2ccccc12)CCN5[C@H]3[C@](C=4)(CCC5)CC
  • InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1 Y
  • Key:DDNCQMVWWZOMLN-IRLDBZIGSA-N Y
 NY (what is this?)  (verify)

Vinpocetine (ethyl apovincaminate), sold under the brand name Cavinton among others, is a synthetic derivative of the vinca alkaloid vincamine, differing by the removal of a hydroxyl group and by being the ethyl rather than the methyl ester of the underlying carboxylic acid. Vincamine is extracted from either the seeds of Voacanga africana or the leaves of Vinca minor (lesser periwinkle).